Literature DB >> 7786308

Rapid changes in cytochrome P4502E1 (CYP2E1) activity and other P450 isozymes following ethanol withdrawal in rats.

B J Roberts1, S E Shoaf, B J Song.   

Abstract

This study describes the effects of chronic ethanol (ETOH) treatment and withdrawal on the rat hepatic mixed-function mono-oxygenase system. Male Sprague-Dawley rats (150-200 g, 10 per group) were administered ETOH as part of the Lieber-deCarli liquid diet for 3 weeks. Ethanol was removed, and the animals were euthanized at 0, 24, 48, 72 and 168 hr post-withdrawal. Microsomes were prepared, and ethanol-inducible cytochrome P4502E1 (CYP2E1) activity was measured using the enzyme markers N-nitrosodimethylamine demethylase (NDMAd), p-nitrophenol hydroxylase (PNPH) and aniline hydroxylase (AH). Activities were found to be induced significantly after chronic ETOH feeding using all three assays (NDMAd, 5-fold; PNPH, 3.5-fold; AH, 9-fold). Upon ETOH withdrawal, all three activities dropped markedly, with NDMAd and PNPH at control values at 24 hr and all subsequent time points. AH activity remained 3-fold higher than controls at 24, 48 and 72 hr. Western blot analyses showed that immunoreactive CYP2E1 returned to control at 24 hr, consonant with NDMAd and PNPH activities. The prolonged induction of AH activity following ETOH withdrawal indicates that it is not a specific marker of CYP2E1-catalyzed reactions. Collectively, these data are suggestive of a rapid mechanism of CYP2E1 degradation in the rat liver. Of the other parameters investigated in this study, total cytochrome P450 content was increased 2.5-fold after ETOH feeding, with levels dropping markedly 24 hr post-withdrawal. NADPH-dependent cytochrome c reductase activity was unchanged throughout the course of the study. CYP1A1, CYP2B1 and CYP3A activities were assessed by the substrate probes ethoxyresorufin O-dealkylase (EROD), pentoxyresorufin O-dealkylase (PROD) and erythromycin N-demethylase (ERNd). EROD and PROD were induced significantly by ETOH administration (2-fold) at 0 hr, with EROD remaining elevated over controls 24 hr post-withdrawal. Quantitative western blot analysis of CYP1A1 and CYP2B1 revealed a pattern of immunostaining generally consistent with but less variable than levels predicted by the respective substrate markers. Both proteins were induced significantly by chronic ethanol administration (CYP1A1, 1.9-fold; CYP2B1, 4-fold). Induction of these P450 isoforms persisted for several days following withdrawal. In contrast, immunoreactive CYP1A2 was found to decrease significantly (by 30-40%) during ethanol withdrawal (24, 48, 72, 168 hr). ERNd activity was induced significantly by chronic ETOH feeding (2.5-fold) and remained so for 24 hr into the withdrawal period (2-fold). Immunoreactive CYP3A1 was also induced significantly following ETOH administration (0 hr) and 24 hr following withdrawal.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7786308     DOI: 10.1016/0006-2952(95)00098-k

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats.

Authors:  Jie Wan; Lena Ernstgård; Byoung J Song; Susan E Shoaf
Journal:  J Pharm Pharmacol       Date:  2006-01       Impact factor: 3.765

2.  Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.

Authors:  R T Miller; S Miksys; E Hoffmann; R F Tyndale
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

3.  Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation.

Authors:  Huynh Nhu Mai; Naveen Sharma; Eun-Joo Shin; Bao Trong Nguyen; Ji Hoon Jeong; Choon-Gon Jang; Eun-Hee Cho; Seung Yeol Nah; Nam Hun Kim; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2018-04-23       Impact factor: 3.996

4.  Limited Excessive Voluntary Alcohol Drinking Leads to Liver Dysfunction in Mice.

Authors:  Scott A Wegner; Katherine A Pollard; Viktor Kharazia; David Darevsky; Luz Perez; Sanjoy Roychowdhury; Allison Xu; Dorit Ron; Laura E Nagy; Frederic Woodward Hopf
Journal:  Alcohol Clin Exp Res       Date:  2017-01-19       Impact factor: 3.455

5.  Acetaminophen hepatotoxicity in mice: Effect of age, frailty and exposure type.

Authors:  Alice E Kane; Sarah J Mitchell; John Mach; Aniko Huizer-Pajkos; Catriona McKenzie; Brett Jones; Victoria Cogger; David G Le Couteur; Rafael de Cabo; Sarah N Hilmer
Journal:  Exp Gerontol       Date:  2015-11-23       Impact factor: 4.032

6.  Cytochrome P4502E1, oxidative stress, JNK, and autophagy in acute alcohol-induced fatty liver.

Authors:  Lili Yang; Defeng Wu; Xiaodong Wang; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2012-06-27       Impact factor: 7.376

Review 7.  CYP2E1 and oxidative liver injury by alcohol.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2007-11-17       Impact factor: 7.376

8.  The effect of aging on acetaminophen pharmacokinetics, toxicity and Nrf2 in Fischer 344 rats.

Authors:  John Mach; Aniko Huizer-Pajkos; Victoria C Cogger; Catriona McKenzie; David G Le Couteur; Brett E Jones; Rafael de Cabo; Sarah N Hilmer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-07-17       Impact factor: 6.053

9.  The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in Fischer 344 rats.

Authors:  John Mach; Aniko Huizer-Pajkos; Sarah J Mitchell; Catriona McKenzie; Leo Phillips; Alice Kane; Brett Jones; Rafael de Cabo; Victoria Cogger; David G Le Couteur; Sarah N Hilmer
Journal:  Fundam Clin Pharmacol       Date:  2015-11-09       Impact factor: 2.748

10.  N-Acetyl cysteine does not prevent liver toxicity from chronic low-dose plus subacute high-dose paracetamol exposure in young or old mice.

Authors:  Alice Elizabeth Kane; Aniko Huizer-Pajkos; John Mach; Catriona McKenzie; Sarah Jayne Mitchell; Rafael de Cabo; Brett Jones; Victoria Cogger; David G Le Couteur; Sarah Nicole Hilmer
Journal:  Fundam Clin Pharmacol       Date:  2016-02-17       Impact factor: 2.748

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.